Increased prothrombin conversion has been shown to be associated with a prothrombotic phenotype in several populations with an increased risk of thrombosis, including antiphospholipid syndrome patients (26), liver cirrhosis patients (24) and patients infected with COVID-19 (32). This evidence concerns the gene F2 and COVID-19.